查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715309

乳房重建市场：按手术类型、按产品类型、按重组类型、按重组阶段、按年龄组、按最终用户、按应用 - 2025-2030 年全球预测

Breast Reconstruction Market by Surgery Type, Product, Reconstruction Type, Stage of Reconstruction, Age Group, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年乳房重建市场价值为 7.7462 亿美元，预计 2024 年将成长至 8.2071 亿美元，复合年增长率为 6.13%，预计到 2030 年将达到 11.7489 亿美元。

介绍

主要市场统计数据
基准年2023年 7.7462亿美元
预计2024年 8.2071亿美元
预测年份 2030 1,174,890,000美元
复合年增长率（%） 6.13%

乳房重建周围的环境正在进入尖端技术创新和融合的时代。随着医疗保健领域的发展，行业领导者和决策者越来越注重提供个人化解决方案，以改善临床结果和患者满意度。本报告概况了乳房重建的现状，说明了市场动态、变革性转变、细分见解、区域发展以及推动该领域创新的主要企业。

在过去的十年中，对研发的大量投资，加上消费者意识的提高和手术技术的改进，推动了重组手术的发展。随着临床通讯协定的发展，对满足不同患者群体独特需求的客製化解决方案的需求日益增长。这种动态环境为寻求占领新市场和优化手术结果的公司创造了前所未有的机会。

本介绍概述了本报告的内容，为报告奠定了基础。决策者深入了解再形成市场的因素。本报告致力于提供清晰、可操作的资料，并提供全面的叙述，为展望乳房重建未来的技术专家和策略领导者提供指导。

乳房重建市场的变革

近年来，在技术进步和重新定义的手术通讯协定的推动下，乳房重建市场经历了重大变革时期。这段变革时期的主要特征是临床创新的融合和多学科方法对患者照护的整合。

最引人注目的趋势之一是向微创手术的转变。这些程序不仅缩短了恢復时间，而且还改善了美观效果。同时，生物材料的进步使外科医生能够使用专门针对提高安全性和有效性的新产品。新材料和增强型仪器与现有身体组织更加相容，显着减少併发症并改善整体患者体验。

此外，监管机构正在逐步简化创新产品的核准流程。这些激励措施有助于加快新的重组解决方案进入市场，从而使最佳实践能够迅速传播。许多专科中心目前正在采用基于证据的通讯协定，结合这些新工具，使患者护理在临床环境中更加个人化和一致。

市场也在回应人口结构的变化，越来越重视以病人为中心的照护。增强的诊断程序和后续护理方案正在重塑治疗模式，使得更准确地预测手术结果和改善长期效果成为可能。随着影像和 3D 建模技术的进步，临床医生已经能够更好地根据患者的生理和心理需求规划重组手术。

总的来说，这些转型变化表明，一个不断变化的格局将在其中推动业务绩效。新技术与成熟手术技术的结合为乳房重建的品质和效率设定了新的标准。

关键细分市场洞察

乳房重建市场已透过多方面的框架进行细分，以便深入了解各种影响因素。从手术类型分析，手术一般分为双侧手术和单侧手术。这些差异反映了不同的临床策略和患者偏好，从而影响治疗结果和復健状况。随着时间的推移，这些手术技术已经发展到可以同时解决重组的美观和功能问题。

随着透过 Aceral 真皮基质、乳房植入、组织扩张器等类别对市场进行研究，产品细分进一步丰富了分析。乳房植入进行了详细分析，区分了生理食盐水和硅胶乳房植入，植入植入物在安全性、质地和整体患者满意度方面都有自己的优势。类似地，组织扩张器分为空气组织扩张器和生理食盐水扩张器，这两种分类满足了重组过程中对扩张能力和病患舒适度的不同要求。这种基于产品的细分至关重要，因为它使相关人员能够识别并投资符合患者趋势和新兴手术方法的创新。

在重组类型方面，市场主要分为皮瓣重组和以植入为基础的重组。虽然皮瓣重组使用患者自身的组织来实现自然轮廓，但基于植入的重组提供了一种侵入性较小的方法，并且可以与各种辅助手术相结合，以进一步优化治疗结果。分割的另一个重要方面是重组阶段，重组包括延迟重建和即时重组。即时重组透过与正在进行的肿瘤手术紧密同步并减少乳房切除术相关的创伤，提供了美学和心理方面的益处，而延迟重组则为患者病情稳定后的手术计划和实施提供了灵活性。

年龄组细分揭示了市场中的更多细微差别。患者被分为 30-50 岁、50 岁以上和 30 岁以下年龄组，每组面临不同的临床情况和优先事项。例如，年轻患者可能优先考虑美观效果，而老年患者可能重视功能恢復和长寿。最终使用者部分涵盖诊所、医院和专科外科中心，凸显了不同医疗环境中技术采用和程序专业知识的多样性。每一个方面都有助于全面了解不同服务提供者之间的动态差异。

最后，从多个观点评估乳房重建的应用，包括解决先天性异常、乳房肿瘤切除术后重组、乳房切除术后重组以及损伤或创伤后的修復。多样化的应用凸显了重组技术的广泛相关性，并强调了扩充性的市场机会。从这些细分参数中，该报告提供了细緻的见解，有助于制定策略计划并使产品开发与不断变化的临床现实保持一致。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球乳癌发生率上升，重组手术需求增加
      • 美容整形手术中乳房重建手术的使用增加
      • 加强医疗报销政策将提高乳房重建的可负担性和可近性。
    • 限制因素
      • 乳房重建手术中使用的生理食盐水植入召回引发担忧
    • 机会
      • 加强研发力度，开发生物相容性乳房植入
      • 持续开发先进的 3D 影像技术，以改善术前规划和结果
    • 任务
      • 对乳房重建中硅胶植入的长期耐用性和安全性的担忧
  • 市场区隔分析
    • 手术类型：双侧乳癌预防的重要性日益增加
    • 产品：硅胶乳房植入对于更自然的感觉和外观的重要性
    • 重组类型：由于手术操作简单、恢復时间短，基于植入的重组的采用正在增加。
    • 重组阶段：人们越来越需要即时重组过程并增加心理方面的益处。
    • 年龄层：为了获得长期健康和美容效果，30-50 岁年龄层的女性越来越多地选择乳房重建手术
    • 最终使用者：扩大乳房重建植入在私人医疗环境中的临床应用
    • 应用：乳房切除术后重组在因癌症而切除整个乳房的女性中得到越来越广泛的应用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章乳房重建市场（依手术类型）

  • 双边
  • 片面

第七章乳房重建市场：依产品

  • 去细胞真皮基质
  • 乳房植入
    • 生理食盐水乳房植入
    • 硅胶乳房植入
  • 组织扩张器
    • 空气组织扩张器
    • 生理食盐水扩容剂

第八章乳房重建市场（依重组类型）

  • 皮瓣重组
  • 植入重组

第九章乳房重建市场（依重建阶段）

  • 恢復延迟
  • 即时重组

第 10 章乳房重建市场（依年龄层）

  • 30～50
  • 50岁或以上
  • 30岁以下

第 11 章乳房重建市场（按最终用户划分）

  • 诊所
  • 医院
  • 专科手术中心

第 12 章乳房重建市场：依应用

  • 先天性异常
  • 乳房切除术后重组
  • 乳房切除术后重组
  • 受伤或创伤后的恢復

13.美洲乳房重建市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

14.亚太乳房重建市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

15. 欧洲、中东和非洲乳房重建市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 4Tissue
  • AbbVie Inc.
  • BELLASENO GmbH
  • Bimini Health Tech
  • Cerecare SAS
  • CollPlant Biotechnologies Ltd
  • DefyGravity by Apex Medical Device Design, LLC.
  • Establishment Labs Holdings, Inc.
  • GC Aesthetics
  • Guangzhou Wanhe Plastic Material Co.,Ltd
  • Hans Biomed Co.
  • Implantech Associates Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Laboratoires Arion
  • Lattice Medical SAS
  • PMT Corporation
  • POLYTECH Health & Aesthetics
  • RTI surgical
  • Sientra, Inc. by Tiger Aesthetics Medical, LLC
  • Silimed Inc.
  • Symatese SAS
Product Code: MRR-437D45958701

The Breast Reconstruction Market was valued at USD 774.62 million in 2023 and is projected to grow to USD 820.71 million in 2024, with a CAGR of 6.13%, reaching USD 1,174.89 million by 2030.

Introduction

KEY MARKET STATISTICS
Base Year [2023] USD 774.62 million
Estimated Year [2024] USD 820.71 million
Forecast Year [2030] USD 1,174.89 million
CAGR (%) 6.13%

The breast reconstruction landscape is witnessing an era of innovation and integration of advanced technologies. Amid an evolving healthcare environment, industry leaders and decision-makers are increasingly focused on offering personalized solutions that enhance clinical outcomes and patient satisfaction. This report provides an executive overview of the current state of breast reconstruction, including market dynamics, transformative shifts, segmentation insights, regional developments, and key players driving innovation in the space.

Over the past decade, significant investments in research and development, coupled with heightened consumer awareness and improved surgical techniques, have catalyzed the evolution of reconstructive procedures. As clinical protocols advance, there is a growing demand for tailored solutions that address the unique needs of diverse patient groups. This dynamic setting presents unprecedented opportunities for entities aiming to capture new markets and optimize surgical results.

This introduction sets the stage by outlining the breadth of the report. Decision-makers will gain insight into the factors that are reshaping the market. The emphasis is on presenting clear, actionable data, and offering a comprehensive narrative that speaks to both technical experts and strategic leaders looking to navigate the future of breast reconstruction.

Transformative Shifts in the Global Landscape

Over recent years, the breast reconstruction market has undergone profound transformative shifts, stimulated by both technological advancements and a redefinition of surgical protocols. This period of change is chiefly characterized by the convergence of clinical innovation and the integration of multidisciplinary approaches to patient care.

One of the most compelling trends is the shift towards minimally invasive techniques. These procedures have not only reduced recovery times but have also improved aesthetic outcomes. Simultaneously, advancements in biomaterials have empowered surgeons to access novel products that are tailored to improve both safety and efficacy. New materials and enhanced devices now offer improved compatibility with existing human tissue and significantly reduce complications, thereby elevating the overall patient experience.

Furthermore, regulatory agencies are progressively streamlining their approval processes for innovative products. This facilitation has accelerated the entry of novel reconstruction solutions into the market, which in turn enables faster dissemination of best practices. Many centers of excellence are now adopting evidence-based protocols that incorporate these new tools, ensuring that patient care is both personalized and consistent across various clinical settings.

The market is also responding to demographic shifts, where an emphasis on patient-centric care is increasingly prominent. Enhanced diagnostic procedures and follow-up care protocols are reshaping treatment paradigms, making it possible to better predict surgical outcomes and improve long-term results. With improved imaging and 3D modeling techniques, clinicians are now more adept at planning reconstructive surgeries that align with the physical and psychological needs of patients.

Overall, these transformative shifts illustrate a landscape in flux, where adaptation and innovation drive performance. The synthesis of new technologies with established surgical practices is setting a new benchmark for quality and efficiency in breast reconstruction.

Key Segmentation Insights

The breast reconstruction market is segmented through a multifaceted framework that allows for a detailed understanding of various influencing factors. An analysis of the landscape by surgery type shows that procedures are generally categorized into bilateral and unilateral approaches. This distinction reflects differences in clinical strategy and patient preference, thereby affecting treatment outcomes and recovery profiles. Over time, these surgical modalities have evolved to address both aesthetic and functional components of reconstruction.

Product segmentation further enriches the analysis as the market is examined through categories such as acellular dermal matrices, breast implants, and tissue expanders. Breast implants are analyzed in depth by distinguishing between saline breast implants and silicone breast implants, each presenting unique benefits in terms of safety, texture, and overall patient satisfaction. Similarly, tissue expanders have also been segmented into air tissue expander and saline expander, a categorization that caters to varying requirements regarding expansion capabilities and patient comfort during the reconstruction process. These product-based distinctions are crucial as they allow stakeholders to identify and invest in innovations that align with patient trends and emerging surgical practices.

In the domain of reconstruction type, the market is primarily divided between flap reconstruction and implant-based reconstruction. While flap reconstruction involves using the patient's own tissue to achieve natural contours, implant-based reconstruction offers a less invasive approach and can often be combined with a range of adjunct procedures to further optimize outcomes. Another essential facet of segmentation is the stage of reconstruction, which includes both delayed reconstruction and immediate reconstruction. Immediate reconstruction synchronizes closely with ongoing oncological procedures, providing aesthetic and psychological benefits by mitigating the trauma associated with mastectomy, whereas delayed reconstruction offers flexibility in planning and executing the surgery once the patient has stabilized.

Age group segmentation reveals further nuances in the market. Patients are categorized into groups spanning ages 30 to 50, above 50, and below 30, each group facing distinct clinical scenarios and priorities. For example, younger patients may prioritize aesthetic outcomes while older patients might weigh functional recovery and longevity more heavily. End user segmentation, which covers clinics, hospitals, and specialty surgical centers, highlights the variability of technological adoption and procedural expertise across different medical settings. Each of these facets contributes to a comprehensive understanding of how dynamics differ among service providers.

Lastly, the application of breast reconstruction is evaluated from multiple perspectives: addressing congenital abnormalities, post-lumpectomy reconstruction, post-mastectomy reconstruction, and restoration after injury or trauma. The diverse applications emphasize the broad relevance of reconstructive techniques and underscore the scalability of market opportunities. In essence, by drawing from these segmentation parameters, the report offers nuanced insights that inform strategic initiatives and help align product development with changing clinical realities.

Based on Surgery Type, market is studied across Bilateral and Unilateral.

Based on Product, market is studied across Acellular Dermal Matrices, Breast Implants, and Tissue Expanders. The Breast Implants is further studied across Saline Breast Implants and Silicone Breast Implants. The Tissue Expanders is further studied across Air Tissue Expander and Saline Expander.

Based on Reconstruction Type, market is studied across Flap Reconstruction and Implant-Based Reconstruction.

Based on Stage of Reconstruction, market is studied across Delayed Reconstruction and Immediate Reconstruction.

Based on Age Group, market is studied across 30-50, Above 50, and Below 30.

Based on End User, market is studied across Clinics, Hospitals, and Specialty Surgical Centers.

Based on Application, market is studied across Congenital Abnormalities, Post-Lumpectomy Reconstruction, Post-Mastectomy Reconstruction, and Restoration After Injury or Trauma.

Key Regional Insights

Regional analysis provides a granular view of the global breast reconstruction market, revealing distinct trends across geographies. The Americas have observed robust growth in adoption rates spurred by strong healthcare infrastructure and high patient awareness of reconstructive options. Continuous investments in research and development have contributed to the availability of advanced reconstructive materials and procedures, which in turn are propelling market expansion in this region.

Moving to the Europe, Middle East & Africa (EMEA) region, there is a noticeable shift towards harmonizing regulatory standards and increasing collaborations among international research bodies. This impetus is driving the diffusion of innovative reconstructive techniques, along with a greater focus on personalized patient care. Markets in this region benefit significantly from the confluence of traditional clinical practices and scientific advancements, providing a balanced approach that is receptive to both emerging trends and established methods.

In the Asia-Pacific region, market potential is largely driven by a rapidly expanding middle class and escalating demand for cosmetic and reconstructive procedures. Increased urbanization coupled with enhanced access to modern healthcare has made the region particularly attractive for investments in breast reconstruction. Technological advancements are rapidly diffusing across the region, aided by government-driven health initiatives and increased patient education. As a result, the diverse needs of populations in this geography are leading to the development of customized reconstructive solutions that cater to varying cultural and economic contexts.

Each region presents its own unique set of challenges and opportunities. Data-driven insights are enabling market participants to tailor their strategies to local preferences while also capitalizing on global trends. This integrated approach not only ensures a more reactive model to clinical and market evolutions but also sets a framework for sustained investment in innovation and patient care.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

A detailed review of leading companies in the breast reconstruction market provides critical insights into the competitive landscape. Market leaders and emerging innovators are pushing the boundaries of reconstructive solutions through a robust portfolio of products, research efforts, and clinical partnerships. Companies such as 4Tissue are distinguished by their commitment to cutting-edge tissue engineering, while AbbVie Inc. is leveraging expansive clinical trials and strategic collaborations to foster the development of next-generation therapeutic solutions.

Other noteworthy players include BELLASENO GmbH and Bimini Health Tech, both of which have been at the forefront of integrating advanced biomaterials with surgical techniques. Cerecare SAS and CollPlant Biotechnologies Ltd have innovated in the realm of acellular dermal matrices, turning traditional reconstruction on its head with solutions that promote rapid healing and reduced post-operative complications. DefyGravity by Apex Medical Device Design, LLC. has set new benchmarks in the design and execution of implant-based procedures, underscoring the importance of precision engineering in medical device development.

Establishment Labs Holdings, Inc. is recognized for its expansive market footprint and effective portfolio management across various reconstructive solutions, while GC Aesthetics has capitalized on its strong research network to refine implant-based methods. Guangzhou Wanhe Plastic Material Co.,Ltd, Hans Biomed Co., and Implantech Associates Inc. have collectively contributed to industry advancements by introducing innovative materials that increase the durability and compatibility of reconstruction implants.

The narrative continues with Integra LifeSciences Holdings Corporation and Johnson & Johnson Services, Inc., both pivotal in shaping clinical best practices through extensive clinical research and product innovation. Laboratoires Arion and Lattice Medical SAS are noted for their bespoke approach to tissue engineering, ensuring that patient care is personalized and adaptable to rapidly changing clinical needs.

Other significant entities like PMT Corporation, POLYTECH Health & Aesthetics, RTI surgical, and Sientra, Inc. by Tiger Aesthetics Medical, LLC have emerged as key players in the market segment, underpinned by their targeted marketing strategies and clinically validated product lines. Silimed Inc. and Symatese SAS round off the list with their innovative contributions that are consistently pushing the envelope on safety, efficacy, and patient satisfaction.

The combined efforts of these companies have been instrumental in the proliferation of new technologies and procedures across the breast reconstruction market. Their continuous investments in research, development, and clinical trials have not only enhanced market competitiveness but also improved the quality of life for countless patients through more refined and effective reconstructive methods.

The report delves into recent significant developments in the Breast Reconstruction Market, highlighting leading vendors and their innovative profiles. These include 4Tissue, AbbVie Inc., BELLASENO GmbH, Bimini Health Tech, Cerecare SAS, CollPlant Biotechnologies Ltd, DefyGravity by Apex Medical Device Design, LLC., Establishment Labs Holdings, Inc., GC Aesthetics, Guangzhou Wanhe Plastic Material Co.,Ltd, Hans Biomed Co., Implantech Associates Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Laboratoires Arion, Lattice Medical SAS, PMT Corporation, POLYTECH Health & Aesthetics, RTI surgical, Sientra, Inc. by Tiger Aesthetics Medical, LLC, Silimed Inc., and Symatese SAS. Actionable Recommendations for Industry Leaders

In navigating the future of breast reconstruction, industry stakeholders must embrace strategies that are both adaptive and forward-thinking. It is paramount for leaders to invest in innovative platforms that harness the latest clinical research and technological advancements. Prioritizing multidisciplinary collaborations among surgeons, radiologists, biomedical engineers, and research institutions can provide a more integrated approach to product development and patient care.

Organizations should channel resources into the development of flexible and scalable solutions that align with the diverse segmentation insights detailed in the analysis. Leveraging innovations such as advanced biomaterials and improved imaging technology can markedly enhance surgical precision and patient-specific outcomes. Industry pioneers must remain agile in their response to the evolving regulatory landscape by fostering closer ties with policy-makers and clinical bodies, ensuring expedited access to emerging technologies.

Strategically examining regional market potentials is equally critical. In regions where infrastructures are undergoing significant transformation, leaders are advised to set up localized research hubs and forge regional partnerships. This localized approach can help in tailoring new products to the specific needs of different demographics, ultimately enhancing market penetration and patient accessibility. Moreover, a stronger emphasis on post-operative care and long-term patient feedback loops will enable companies to continuously improve their offerings and build enduring trust with healthcare providers.

Investments in digital transformation, including the implementation of telemedicine and data analytics, can significantly streamline patient management and drive operational efficiencies. These technologies support the creation of integrated health management systems that are particularly beneficial in optimizing pre- and post-surgical care protocols. By enhancing the overall patient journey-from diagnosis through long-term management-providers can ensure higher satisfaction rates and improved clinical outcomes.

In summary, industry leaders should focus on a multifaceted strategy that incorporates innovation, regional customization, and technology integration. By adopting a proactive approach that aligns with current trends and future expectations, organizations can secure sustainable growth, mitigate operational risks, and ultimately advance the standard of care in breast reconstruction.

Conclusion

The breast reconstruction market is at a pivotal juncture, influenced by remarkable technological advancements, evolving patient preferences, and robust clinical innovations. This comprehensive overview underscores the dynamic interplay between surgical techniques, product innovation, and demographic trends. The segmentation insights provide a layered understanding of surgical options, product differentiations, and application scopes, while regional analyses illuminate both opportunities and challenges across the globe.

Key industry players are at the forefront of driving transformative changes, as evidenced by their diverse portfolios and commitment to improving patient outcomes. Their collaborative approach in embracing new technologies and adapting to regulatory nuances has reshaped the landscape, making it more competitive and consumer-centric than ever before.

Moreover, actionable recommendations for industry leaders reveal strategies that other stakeholders can adopt to harness market potential and forge a path toward sustainable growth. With opportunities for continued innovation and a focus on personalized patient care, the future of breast reconstruction is filled with promise. This report not only captures the current state of play but also provides a robust framework for future developments, making it an essential resource for anyone looking to understand or invest in this rapidly evolving arena.

In conclusion, the market's trajectory points to a future where clinical advancements and patient-centric innovations converge to elevate the standards of care. Decision-makers are encouraged to remain agile, prioritize data-driven insights, and maintain a forward-thinking posture to remain competitive in the dynamic landscape of breast reconstruction.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of breast cancer globally necessitating reconstruction surgeries
      • 5.1.1.2. Increasing implementation of breast reconstruction procedures for cosmetic correction
      • 5.1.1.3. Enhanced healthcare reimbursement policies improve affordability and accessibility of breast reconstruction
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with the recall of saline implants used in breast reconstruction surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research and development activities for development of biocompatible breast implants
      • 5.1.3.2. Ongoing development of advanced 3D imaging technologies for better pre-surgical planning and outcomes
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with long-term durability and safety of silicone implants in breast reconstruction
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Surgery Type: Growing significance of bilateral breast reconstruction preventive measure for breast cancer
    • 5.2.2. Product: High importance of silicone breast implants for a more natural feel and appearance
    • 5.2.3. Reconstruction Type: Increasing adoption of implant-based reconstruction owing to less complex surgical procedure with a shorter recovery time
    • 5.2.4. Stage of Reconstruction: Proliferating need for immediate reconstruction process with improved psychological benefits
    • 5.2.5. Age Group: Increasing breast reconstruction surgeries in the 30-50 age group due to long-term health and aesthetic outcomes
    • 5.2.6. End User: Extending usage of breast reconstruction implants in clinics for intimate healthcare setting
    • 5.2.7. Application: Growing applications of post-mastectomy reconstruction for individuals who have had their entire breasts removed due to cancer
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Breast Reconstruction Market, by Surgery Type

  • 6.1. Introduction
  • 6.2. Bilateral
  • 6.3. Unilateral

7. Breast Reconstruction Market, by Product

  • 7.1. Introduction
  • 7.2. Acellular Dermal Matrices
  • 7.3. Breast Implants
    • 7.3.1. Saline Breast Implants
    • 7.3.2. Silicone Breast Implants
  • 7.4. Tissue Expanders
    • 7.4.1. Air Tissue Expander
    • 7.4.2. Saline Expander

8. Breast Reconstruction Market, by Reconstruction Type

  • 8.1. Introduction
  • 8.2. Flap Reconstruction
  • 8.3. Implant-Based Reconstruction

9. Breast Reconstruction Market, by Stage of Reconstruction

  • 9.1. Introduction
  • 9.2. Delayed Reconstruction
  • 9.3. Immediate Reconstruction

10. Breast Reconstruction Market, by Age Group

  • 10.1. Introduction
  • 10.2. 30-50
  • 10.3. Above 50
  • 10.4. Below 30

11. Breast Reconstruction Market, by End User

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Specialty Surgical Centers

12. Breast Reconstruction Market, by Application

  • 12.1. Introduction
  • 12.2. Congenital Abnormalities
  • 12.3. Post-Lumpectomy Reconstruction
  • 12.4. Post-Mastectomy Reconstruction
  • 12.5. Restoration After Injury or Trauma

13. Americas Breast Reconstruction Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Breast Reconstruction Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Breast Reconstruction Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Mentor Worldwide MemoryGel enhance breast implants approved by FDA for expanded reconstruction options
    • 16.3.2. 4Tissue secures EUR 2M to propel innovative breast tissue regeneration technology
    • 16.3.3. Establishment Labs receives FDA approval for innovative Motiva breast implants
    • 16.3.4. GC Aesthetics launch YOUTHLY brand in China to enhance breast implant innovations
    • 16.3.5. POLYTECH launch Opticon plus to expanding breast implant portfolio
    • 16.3.6. Melodi Health secures series A funding to launch trial for post-surgical infection solutions in breast reconstruction
    • 16.3.7. NIH-funded research team develops next level breast reconstruction techniques to enhance post-cancer recovery
    • 16.3.8. CollPlant and Stratasys collaborate for pre-clinical study of regenerative 3D printed breast implants
    • 16.3.9. Bimini Health Tech launch serene structured saline breast implants
    • 16.3.10. GC Aesthetics launch FixNip NRI to transform breast reconstruction post-mastectomy
    • 16.3.11. RTI Surgical received FDA IDE approval for Cortiva allograft dermis clinical trials in breast reconstruction
    • 16.3.12. Bimini Health Tech subsidiary acquires substantially all of The Ideal Implant, Inc. assets
  • 16.4. Strategy Analysis & Recommendation
    • 16.4.1. Establishment Labs Holdings, Inc.
    • 16.4.2. GC Aesthetics
    • 16.4.3. AbbVie Inc.
    • 16.4.4. Johnson & Johnson Services, Inc.

Companies Mentioned

  • 1. 4Tissue
  • 2. AbbVie Inc.
  • 3. BELLASENO GmbH
  • 4. Bimini Health Tech
  • 5. Cerecare SAS
  • 6. CollPlant Biotechnologies Ltd
  • 7. DefyGravity by Apex Medical Device Design, LLC.
  • 8. Establishment Labs Holdings, Inc.
  • 9. GC Aesthetics
  • 10. Guangzhou Wanhe Plastic Material Co.,Ltd
  • 11. Hans Biomed Co.
  • 12. Implantech Associates Inc.
  • 13. Integra LifeSciences Holdings Corporation
  • 14. Johnson & Johnson Services, Inc.
  • 15. Laboratoires Arion
  • 16. Lattice Medical SAS
  • 17. PMT Corporation
  • 18. POLYTECH Health & Aesthetics
  • 19. RTI surgical
  • 20. Sientra, Inc. by Tiger Aesthetics Medical, LLC
  • 21. Silimed Inc.
  • 22. Symatese SAS

LIST OF FIGURES

  • FIGURE 1. BREAST RECONSTRUCTION MARKET MULTI-CURRENCY
  • FIGURE 2. BREAST RECONSTRUCTION MARKET MULTI-LANGUAGE
  • FIGURE 3. BREAST RECONSTRUCTION MARKET RESEARCH PROCESS
  • FIGURE 4. BREAST RECONSTRUCTION MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 21. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 25. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 30. BREAST RECONSTRUCTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 31. BREAST RECONSTRUCTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BREAST RECONSTRUCTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BREAST RECONSTRUCTION MARKET DYNAMICS
  • TABLE 7. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY BILATERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY ACELLULAR DERMAL MATRICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SALINE BREAST IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SILICONE BREAST IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY AIR TISSUE EXPANDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SALINE EXPANDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY FLAP RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY IMPLANT-BASED RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY DELAYED RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY IMMEDIATE RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY 30-50, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY ABOVE 50, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY BELOW 30, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY CONGENITAL ABNORMALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY POST-LUMPECTOMY RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY POST-MASTECTOMY RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY RESTORATION AFTER INJURY OR TRAUMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES BREAST RECONSTRUCTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 288. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR BREAST RECONSTRUCTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 331. RUSSIA BREAST RECONSTRUCTION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. RUSSIA BREAST RECONSTRUCTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 333. RUSSIA BREAST RECONSTRUCTION MARKET SIZE, BY BREAST IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 334. RUSSIA BREAST RECONSTRUCTION MARKET SIZE, BY TISSUE EXPANDERS, 2018-2030 (USD MILLION)
  • TABLE 335. RUSSIA BREAST RECONSTRUCTION MARKET SIZE, BY RECONSTRUCTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA BREAST RECONSTRUCTION MARKET SIZE, BY STAGE OF RECONSTRUCTION, 2018-2030 (US